CGP60474 is primarily utilized in research settings as a potent and selective inhibitor of cyclin-dependent kinases (CDKs), particularly CDK1, CDK2, and CDK5. Its application is significant in studying cell cycle regulation and understanding the mechanisms of cancer progression, as CDKs play a crucial role in controlling cell division. Researchers use it to investigate the effects of CDK inhibition on tumor growth and to explore potential therapeutic strategies for cancer treatment. Additionally, it serves as a valuable tool in biochemical assays to elucidate the roles of specific CDKs in various cellular processes, aiding in the development of targeted therapies.